baber/WOPTO huggingface dataset:
Patent AU-2004277897-B2 (AU)
Title: Catheter-based fastener implantation apparatus and methods with implantation force resolution
Inventor: PARODI JUAN C
IPC: A61B17/068
Filed: 2004-09-10
Granted: 2011-07-07
Abstract: Apparatus and methods implant a fastener in a targeted body region, e.g., a hollow body cavity or an intraluminal space. The apparatus and methods deploy in targeted body region a fastener attachment assembly that carries an actuated member. The actuated member is selectively operable to generate an implantation force to implant a fastener into tissue within the targeted body region. The fastener can be implanted, e.g., to secure a prosthesis, e.g., an endovascular graft. The systems and apparatus apply a resolution force at or near the actuated member, thereby making possible a stable and dependable catheter-based fastening platform.
Patent AU-2004298980-B2 (AU)
Title: Multiple section parenteral drug delivery apparatus
Inventor: DEAN DRINAN DARREL
IPC: A61K9/00
Filed: 2004-12-09
Granted: 2011-08-18
Abstract: The invention relates to a parenteral therapeutic agent delivery device. The therapeutic agent delivery device has a disposable section and an implant section suitable for long term implantation within the tissue of a subject. When necessary, the disposable section can be detached from the implant section, and a new disposable section can be attached. The disposable section may contain a reservoir containing the therapeutic agent, a pump for dispensing the therapeutic agent, controlling circuitry for regulating the dispensing of the therapeutic agent, and transceiver circuitry and an antenna for wireless communication with external devices.
Patent AU-2005315878-B2 (AU)
Title: Signal converter for converting a start signal into a final signal and method for converting a start signal into an end signal
Inventor: BREILING MARCO
IPC: H04L27/26
Filed: 2005-12-12
Granted: 2009-10-08
Abstract: A signal converter for converting a start signal into an end signal includes means for copying the start signal to obtain a plurality of copied start signals, wherein a copied start signal may be fed into a processing branch as a branch signal. Further, the signal converter includes a first branch processing means in a first processing branch for processing a first branch signal according to a first processing regulation to obtain a first processed branch signal. Further, the signal converter includes a second branch processing means in a second processing branch for processing a second branch signal according to a second processing regulation to obtain a second processed branch signal, wherein the second processing regulation is different from the first processing regulation and wherein the first processing regulation and the second processing regulation are implemented to cause a low-pass polyphase filtering of the copied start signals. Finally, the signal converter includes selection means for sequentially selecting the first processed branch signal and then the second processed branch signal in order to obtain the end signal.
Patent AU-2005318290-B2 (AU)
Title: Polishing wheel
Inventor: LOIC QUERE
IPC: B24B13/01
Filed: 2005-12-21
Granted: 2011-08-25
Abstract: A polishing wheel (10) arranged to polish an article. The polishing wheel comprises a hub (12) provided with an axial cavity (18)coaxial with an axis (26). The polishing wheel further comprises a substrate layer (14) being made of an elastomer material affixed to the hub (12) and coaxial with the axis (26). The substrate layer (14) has an outer surface (20) having a substantially symmetrical shape with respect to the axis (26). The polishing wheel (10) further comprises a continuous cover layer (16) affixed to the outer surface (20) and coaxial with the axis (26). The continuous cover layer (16) is made of an elastomer material covering substantially entirely the outer surface (20).
Patent AU-2006220248-B2 (AU)
Title: Compounds having lipid lowering properties
Inventor: LIBINAKI ROKSAN
IPC: A61P9/00
Filed: 2006-03-03
Granted: 2012-06-21
Abstract: There is provided a therapy for lowering the blood levels of a lipid selected from the group comprising LDL cholesterol, triglycerides, overall cholesterol and mixtures thereof, the therapy comprising the step of administering an effective amount of one or more phosphate derivatives of one or more electron transfer agents.
Patent AU-2006321321-B2 (AU)
Title: Method for determining the concentration of the adipocytic form of the fatty acid binding protein (A-FABP, FABP4, P2)
Inventor: RUZICKA VIKTOR
IPC: A61P3/10
Filed: 2006-07-21
Granted: 2011-07-28
Abstract: The invention relates to products and methods for the research, diagnosis, risk assessment, course monitoring, treatment and prophylaxis of various metabolic disorders and their early forms, concomitant diseases and secondary diseases. Metabolic diseases in the aforementioned sense include, among others, metabolic syndrome, non-insulin-dependent diabetes, (type II diabetes), insulin resistance, obesity (adiposis), in addition to diseases that are associated with disorders of the fatty acid metabolism. The inventive methods can be used, among other things, for determining the concentration of the adipocytic form of the fatty acid binding protein (A-FABP, FABP 4, P2) in various bodily fluids.
Patent AU-2006329837-B2 (AU)
Title: Microaggregates including endothelial cells
Inventor: WEISENTHAL LARRY MARK
IPC: C12N5/09
Filed: 2006-12-15
Granted: 2012-12-06
Abstract: Microaggregates which mimic the native environment of cells contained in biopsied tissue are used to assess and predict the effects of various treatments on the viability of cell types contained in the microaggregate.
Patent AU-2006330922-B2 (AU)
Title: Compositions and methods for producing a composition
Inventor: DONALDSON ROBERT
IPC: A61K38/17
Filed: 2006-12-19
Granted: 2012-07-26
Abstract: The invention provides for mammalian cells capable of producing recombinant CTLA4-Ig and variants thereof. The invention also provides for compositions comprising CTLA4-Ig and formulations thereof. The invention further provides for methods for mass- producing CTLA4-Ig from mammalian cells capable of producing this recombinant protein, and for purifying the CTLA4-Ig.
Patent AU-2007206647-B2 (AU)
Title: Process for manufacturing particles based on natural calcium carbonate and salts of acrylic acid-ethylene, suspensions and dry pigments obtained, and uses thereof
Inventor: HUNZIKER PHILIPP
IPC: C08K3/00
Filed: 2007-01-09
Granted: 2012-09-27
Abstract: The present invention consists in a process for preparing at least one mineral material and/or at least one pigment, comprising a calcium carbonate made both partially organophilic and partially hydrophilic, wherein the carbonate is mixed and/or ground and/or concentrated in aqueous medium in the presence of at least one salt of ethylene acrylic acid, a dispersant and/or grinding aid being introduced before and/or during this treatment step. Another subject of the invention lies in the resulting dispersions and aqueous suspensions of calcium carbonate. They may be dried, and the dry pigments obtained likewise constitute a subject of the invention. The use of these aqueous dispersions and of these dry pigments in the field of plastics, paints and paper constitutes another subject of the invention.
Patent AU-2007226658-B2 (AU)
Title: In vivo induced genes of Mycobacterium tuberculosis
Inventor: HILLMAN JEFFREY D
IPC: C07K16/12
Filed: 2007-03-13
Granted: 2011-10-27
Abstract: The invention provides compositions and methods for the detection of .
Patent AU-2007306226-B2 (AU)
Title: Novel morphine derivatives
Inventor: LAHANA ROGER
IPC: A61K31/7048
Filed: 2007-10-11
Granted: 2012-01-19
Abstract: The present invention relates to novel morphine-6-glucuronide derivatives, to pharmaceutical compositions containing them and to uses thereof. Said derivatives have the following structures, where the group Pcntite (A), except substituents X, is called M6G-NR1 R2-S-, R1 = saturated or unsaturated, straight- or branched-chain C-Calkyl, the alkyl chain being optionally interrupted by one or more heteroatoms selected from O, S and N, R2 = H, saturated or unsaturated, straight- or branched-chain C-Calkyl, or an aryl, heteroaryl or (C-C) alkylaryl group, R3 = Y(C=Z)R or YR, Y and Z independently = O or S, R = saturated or unsaturated, straight- or branched-chain C-C alkyl with the proviso that R3 is not -O-CHX = H, an -S-R4-W group, or a MR,6G-NR I R2-S- group, with R4 = saturated or unsaturated, straight- or branched-chain C -Calkyl which can include amide, ester or ether bonds and W is either a δ-receptor antagonist, or a K-receptor antagonist and a pharmaceutically acceptable salt thereof.
Patent AU-2007343079-B2 (AU)
Title: Improvements to printing superimposed layers
Inventor: HILL ROLAND G
IPC: B41M5/00
Filed: 2007-11-14
Granted: 2013-01-17
Abstract: An apparatus and method for making a panel with superimposed layers of marking material in substantially exact registration is provided. An assembly includes a stencil layer (20) sandwiched between a substrate (10) and a transparent coating (30). The stencil includes a release surface (22, 23). The coating (30) tends to secure the stencil layer (20) to the substrate (10), e.g., for storage and/or transport, and may protect the stencil layer (20) from marking materials (49) that might otherwise penetrate the stencil layer (20). A design (40) and background (50, 51) layers are then printed onto the coating. A force is then applied to remove the background layer (50, 51), design layer (40), and coating (30) that are disposed on the stencil layer (20), leaving the remainder of the background layer, design layer, and coating adhered to the substrate (10) in substantially exact registration within portions of the substrate that are devoid (21) of the stencil layer. The design layer is right-reading visible through the substrates.
Patent AU-2007355202-B2 (AU)
Title: Stable organic-carrier-based microbial inoculants and method for producing the same
Inventor: HALOS SATURNINA
IPC: C12N1/20
Filed: 2007-06-21
Granted: 2014-10-09
Abstract: The present invention relates to methods for producing microbial preparations for crop production and microbial preparations produced through such methods. The formulations contain microbial inoculants like Azospirillum spp. which are grown in a complex medium, lyophilized with powdered milk and further supplemented with minerals and vitamins, starch and inert substances such as talc, chalk and diatomaceous earth. The products manufactured by such methods have shelf-lives of more than 3 years. They are used to inoculate seeds, seedlings and planting materials among different agriculture and forestry species for enhancing root, root hair an shoot formation, enabling plants to efficiently use soil nutrients, supplying plants with nitrogen from the air, tolerating drought and protecting plants from root pathogenes.
Patent AU-2008225766-B2 (AU)
Title: Organic compounds and their uses
Inventor: PEREZ LAWRENCE BLAS
IPC: C07D417/14
Filed: 2008-03-13
Granted: 2012-06-07
Abstract: The present disclosure relates to compounds relating to the diagnosis and treatment of pathologies relating to the Hedgehog pathway, including but not limited to tumor formation, cancer, neoplasia, and non-malignant hyperproliferative disorders; specifically relating to compounds of formula (I).
Patent AU-2008251405-B2 (AU)
Title: Improved feed media
Inventor: PINEDA ERIKA
IPC: C12N5/02
Filed: 2008-05-09
Granted: 2012-05-17
Abstract: The invention provides stable feed media containing pyruvate and methods for stabilizing feed media by adding pyruvate. The invention further provides methods for producing proteins using such media and proteins produced through the use of such methods.
Patent AU-2008251610-B2 (AU)
Title: Systems and methods for creation of a schematic user interface for monitoring and predicting the real- time health, reliability and performace of an electrical power system
Inventor: MEAGHER KEVIN
IPC: G06T15/00
Filed: 2008-05-07
Granted: 2013-05-23
Abstract: A system for automatically generating a schematic user interface of an electrical system is disclosed. The system includes a data acquisition component, a power analytics server and a client terminal. The data acquisition component acquires real-time data output from the electrical system. The power analytics server is comprised of a virtual system modeling engine, an analytics engine, a machine learning engine and a schematic user interface creator engine. The virtual system modeling engine generates predicted data output for the electrical system. The analytics engine monitors real-time data output and predicted data output of the electrical system. The machine learning engine stores and processes patterns observed from the real-time data output and the predicted data output to forecast an aspect of the electrical system. The schematic user interface creator engine is configured to create a schematic user interface that is representative of the virtual system model and link the schematic user interface to the data acquisition component.
Patent AU-2008283807-B2 (AU)
Title: (2S,3R)-N-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzofuran-2-carboxamide, novel salt forms, and methods of use thereof
Inventor: GENUS JOHN
IPC: A61P43/00
Filed: 2008-08-01
Granted: 2012-03-29
Abstract: The present invention relates to (2S,3R)-N-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzofuran-2-carboxamide, novel salt forms thereof, methods for its preparation, novel intermediates, and methods for treating a wide variety of conditions and disorders, including those associated with dysfunction of the central and autonomic nervous systems.
Patent AU-2008291662-B2 (AU)
Title: Method for operating copper electrolysis cells
Inventor: ANDREAS FILZWIESER
IPC: C25C7/00
Filed: 2008-08-07
Granted: 2011-10-06
Abstract: In a method for operating copper electrolysis cells which comprise a plurality of anode and cathode plates positioned perpendicularly and parallel to each other, an electrolyte inlet on the longitudinal side and an electrolyte outlet, the electrolyte flows in through the electrolyte inlet horizontally and parallel to the electrodes in each electrode gap at the level of the lower third of the electrodes at a rate of 0.3 to 1.0 m/s, wherein the cathode plates are in a fixed position with respect to the inlet direction. Thus, an optimum flow control of the electrolyte is achieved with respect to the electrodes, which results in an increase in the limiting current density.
Patent AU-2008300432-B2 (AU)
Title: Nucleobase characterisation
Inventor: DIAZ-MOCHON JUAN J
IPC: C07D239/22
Filed: 2008-09-19
Granted: 2015-03-26
Abstract: The present invention provides modified nucleobase compounds, modified nucleic acid mimetic compounds and various uses thereof. In addition, the invention provides methods for nucleobase characterisation, SNP characterisation and nucleic acid sequencing.
Patent AU-2008314974-B2 (AU)
Title: Amine derivative having NPY Y5 receptor antagonist activity and use thereof
Inventor: OKUNO TAKAYUKI
IPC: A61K31/18
Filed: 2008-10-23
Granted: 2013-08-22
Abstract: Disclosed is an appetite suppressant or anti-obesity agent containing a compound represented by the formula (I) below, a pharmaceutically acceptable salt thereof, or a solvate of any of them. (In the formula, R
Patent AU-2008317292-B2 (AU)
Title: Drive for transit door
Inventor: HEIDRICH PETER
IPC: B60J5/06
Filed: 2008-07-24
Granted: 2012-12-06
Abstract: A multi-part drive shaft for a transit vehicle door comprises an upper drive shaft connected to a door operating mechanism and having a door panel operating arm extending therefrom, a lower drive shaft journaled for rotation, a door panel operating arm extending therefrom and a flexible drive shaft secured at one end to the upper drive shaft and at the other end to the lower drive shaft. Rotation of the upper drive shaft will transfer torque to the lower drive shaft at the same angular speed.
Patent AU-2008340019-B2 (AU)
Title: Pharmaceutical composition
Inventor: DEODHAR UNMESH
IPC: A61K31/404
Filed: 2008-12-19
Granted: 2012-05-03
Abstract: The application relates to solid pharmaceutical compositions suitable for oral administration comprising an indolylmaleimide derivative, process for their production and use of the pharmaceutical compositions.
Patent AU-2008341017-B2 (AU)
Title: Multi-part beam
Inventor: FARMILO GRAHAM ANTHONY
IPC: F16S3/00
Filed: 2008-12-19
Granted: 2014-12-18
Abstract: A sill beam inter alia for a crane made of bearer modules joined end to end by bolts. The modules are made of steel channel section components up to 1600 mm in length so that when disassembled they will be manhandlable by two persons and fit in the lift of a building. This permits the beam to move from job to job. When the components are assembled to form a module they create an axial slot through which a bolt can pass to fasten the sill beam to the building or support pad on site. A spacer plate with projecting pins is interposed between successive modules to speed assembly.
Patent AU-2009207774-B2 (AU)
Title: Method and system for deploying non-backward compatible server versions in a client/server computing environment
Inventor: TCHENG CHRISTOPHE
IPC: G06F9/445
Filed: 2009-01-16
Granted: 2014-10-30
Abstract: A method and a system for managing the introduction of a new non-backward compatible version of an application server into a client/server networking environment are described. The method consists in first distributing to a client system to be served by the new non-backward compatible version of the application server a client application operable in a mode compatible with the current version of the application server and in a mode compatible with the new non-backward compatible version. Upon installation in the client system the client application is set into a downgraded mode compatible with the current version of the application server. While the current version of the application server is still in production, the client application is kept operated in the downgraded mode. Upon introduction of the new non-backward compatible version of the application server, the client application is set into a valid mode compatible with the new version of the application server. From that point on, the client application is operated in the valid mode. Setting of the modes is automatically triggered at each re-launch of the client system which queries a version server operating in the client/server networking environment. Query includes an identification of the client system and a client application version number in order to obtain from the queried version server a status value to operate the client system into a mode including the downgraded mode and the valid mode.
Patent AU-2009215627-B2 (AU)
Title: Reducing carbon dioxide (CO2) emissions from the burning of a fossil fuel
Inventor: MCCARTNEY MICHAEL S
IPC: B01D53/34
Filed: 2009-02-17
Granted: 2012-07-05
Abstract: A system (10) for reducing carbon dioxide emissions from gasses generated in burning fossil fuel, includes a vessel (20), separator (38) and reheater (50). The upper portion (12) of the vessel (20) receives downward flowing, first type solid particles capable of absorbing heat from upward flowing gasses (22) and second type solid particles capable of capturing carbon dioxide from the gasses. The separator (38) separates the second type solid particles (26) with the captured carbon dioxide from the gasses discharged from the first vessel discharge, and directs the separated second type solid particles (26) with the captured carbon dioxide to a separator discharge. The reheater (28) directs the first type solid particles and the second type solid particles (24) with the captured carbon dioxide in a downwardly flow to a first reheater discharge, such that heat from the first type solid particles causes the captured carbon dioxide to be released from the second type solid particles (26).
Patent AU-2009261101-B2 (AU)
Title: A pharmaceutical composition comprising rebamipide
Inventor: SUMIDA SHUN-ICHIRO
IPC: A61K47/02
Filed: 2009-06-18
Granted: 2013-11-07
Abstract: An object of the present invention is to provide a pharmaceutical composition containing rebamipide, which is unnecessary to be re-dispersed, has an enough transparency, and exhibits neutral to weakly acidic pH not to injure the keratoconjunctiva of a patient suffering from dry eye. The present pharmaceutical composition comprises (1) rebamipide, (2) an amino sugar, and (3) an buffer agent, which has no inorganic cation.
Patent AU-2009292970-B2 (AU)
Title: Genus-wide Chlamydial peptide vaccine antigens
Inventor: WHITTUM-HUDSON JUDITH
IPC: C12N15/13
Filed: 2009-09-21
Granted: 2015-05-07
Abstract: Peptides generated from a random library that are bound by a monoclonal antibody to Chlamydial glycolipid exoantigen (GLXA) and thus mimic this antigen are disclosed. Peptides that correspond to antigen-binding regions of an anti-idiotypic antibody (mAb2) specific for anti-GLXA antibody (Ab1) which act as molecular mimics of GLXA are also disclosed used as immunogens to induce broadly reactive genus-specific anti-chlamydial antibodies. These peptides and immunogenic DNA encoding the mAb2-like peptides, microparticle or nanoparticle formulations and other formulations of these peptides are disclosed as are methods for immunizing subjects to obtain genus-specific anti-chlamydial antibodies and to treat or prevent Chlamydia-associated or induced rheumatoid arthritis.
Patent AU-2009302956-B2 (AU)
Title: Inhalation device and method of dispensing medicament
Inventor: BAKEWELL WILLIAM
IPC: A61M15/00
Filed: 2009-10-07
Granted: 2012-09-13
Abstract: The present invention relates to an inhaler, comprising a base having at least one air-tight, foil-sealed cavity containing medicament. An actuator is engagable with a separating element attached to the foil, the actuator having an energized position in which it is biased towards an unloaded position so as to cause the separating element and attached foil to be moved away from the cavity. A latch has a first position, in which it latches the actuator in said energized position, wherein the latch is at least partly arranged in a flow path such that an inhalation flow through the flow path affects the latch to move from the first position to the second position. The invention also relates to a method of dispensing a medicament from a sealed cavity inside an inhaler.
Patent AU-2009314391-B2 (AU)
Title: Treatment of tailings streams
Inventor: MOFFETT ROBERT HARVEY
IPC: C04B28/00
Filed: 2009-10-29
Granted: 2012-08-30
Abstract: A process for the treating a mature fine tailings stream is provided. Treatment comprises contacting an alkali metal silicate or polysilicate microgel and an activator with mature fine tailings, entrapping the sand and clay fines within a polysilicate microgel, spreading the silica microgel over a surface, and allowing the silica microgel to dry, and producing a trafficable surface.
Patent AU-2010201311-B2 (AU)
Title: Method of fabricating an array of spherical solar cells
Inventor: DALE HAMMERBACHER MILFRED
IPC: H01L31/0216
Filed: 2010-04-01
Granted: 2011-08-11
Abstract: A method of fabricating a photovoltaic solar cell is provided. A plurality of generally spherical semiconductor elements are provided. Each of the semiconductor elements has a core and an outer surface forming a p-n junction. An anti-reflection coating is deposited on the outer surface of each of the semiconductor elements and each of the semiconductor elements is bonded into a perforated aluminum foil array thereby providing ohmic contact to a first side of the p-n junction. The anti-reflection coating is removed from a portion of each of the semiconductor elements and then the core is exposed, thereby allowing ohmic contact to be made to a second side of the p-n junction. C:\NRPartbl\DCC\MKA\2831527_1 .DOC - 14/10